Corneal inlay

Corneal inlay

AcuFocus has announced that Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, Austria, presented data on the five-year postoperative performance of the KAMRA inlay at the recent 26th International Congress of German Ophthalmic Surgeons (DOC) meeting. According to Dr Grabner’s data, at five years following implantation, patients with the inlay continue to have great vision. He reported, on average in the inlay eye patients achieve J2 uncorrected near visual acuity and 20/25 for both uncorrected intermediate and distance visual acuities. Over this same timeframe the fellow, non-implanted eye, in this same cohort of patients lost lines of near, intermediate and distance visual acuity. “This data underscores that the KAMRA inlay is effective over the long-term, delivering a full range of vision and patient satisfaction,” noted Dr Grabner.

“The safety profile for a corneal procedure is much greater than for a lens-based procedure, making the inlay an ideal ‘first choice’ for presbyopic patients. Since the inlay is removable, should it require removal – a rare occurrence at <2 per cent commercially – the patients still have all options available for presbyopia correction.”

www.AcuFocus.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...